• כרטיס רופא והטבות
  • אתרי הר"י
  • צרו קשר
  • פעולות מהירות
  • עברית (HE)
  • מה תרצו למצוא?

        תוצאת חיפוש

        מאי 2001

        קרן אלישקביץ, יצחק שפירא, שלמה ברלינר
        עמ'

        קרן אלישקביץ, יצחק שפירא, שלמה ברלינר

         

        המח' לרפואה פנימית ד' והיחידה לטיפול בנוגדי קרישה, מרכז רפואי תל אביב סוראסקי והפקולטה לרפואה סאקלר, אוניברסיטת תל אביב

         

        הקשר בין היפרליפידמיה ומחלות לב וכלי דם מוכח וידוע. פחות מוכרת העובדה, שהיפרליפידמיה קשורה בשינויים המוריאולוגיים שעשויים לגרום להאטת זרימת הדם בנימיות. הטיפול בהיפרליפידמיה עשוי לשפר את ההיבטים ההמוריאולוגיים הנ"ל ובכך לתרום להאצת הזילוח הריקמתי. לאור החשיבות הרבה שמייחסים לטיפול תזונתי ותרופתי בהיפרליפידמיה, ולאור התוצאות המיטיבות של טיפול זה, ברצוננו לסכם את ההיבטים ההמוריאולוגיים הקשורים בו. יש בכך כדי להדגיש היבט נוסף המקשר בין היפרליפידמיה ומחלות איסכמיות שונות.

        בסקירה זו, נתרכז בהיבטים השונים הקשורים בכדוריות הדם האדומות.

        מרץ 2001

        אברהם יצחק, גד שקד, ליליאנה לופו, סולי מזרחי ויורם קלוגר
        עמ'

        Selective Embolization of Hepatic Arteries in the Management of Severe Liver Trauma

         

        Avraham Yitzhak1, Gadi Shaked2, Liliana Lupu3, Soli Mizrahi, Yoram Kluger4

         

        1Department of Surgery A, 2Trauma Service, 3Interventional Radiology, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, and Trauma Service4, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

         

        Two cases of severe hepatic injury in which selective hepatic artery embolization was used to control hemorrhage are presented. The first case is that of a 35 year old patient who sustained a severe liver injury after a car accident. A CAT scan of the abdomen revealed an AAST grade 5 liver injury, pooling of contrast material within the liver parenchyma, and blood within the peritoneal cavity. The patient was given fluid resuscitation and taken to angiography where bleeding from branches of the right hepatic artery was demonstrated. While angiography was being undertaken the hemodynamic status of the patient deteriorated, blood transfusion was started, and a selective embolization of the right hepatic artery was performed. The bleeding stopped promptly and hemodynamic stability was regained.

        The second case is that of a 40 year old pedestrian run over by a car. Abdominal ultrasound revealed free fluid in the peritoneal cavity and the patient was rushed to the O.R. Crushed right lobe of the liver, and inferior vena cava and bowel tears were found. After perihepatic packing and resection of the right and sigmoid colons retrohepatic vena cava tear was repaired and perihepatic packing restored. The abdominal cavity was closed and the patient was taken to the ICU for the correction of hypothermia, metabolic acidosis, and coagulopathy that had developed during the surgery. After 8 hours in the ICU the patient was transferred for angiography and a selective embolization of branches of the right hepatic artery was performed.

        The clinical course of the patients after angiographic embolization of the hepatic arteries is described and the literature that discusses the use of angiography and embolization of hepatic arteries after traumatic hepatic bleeding is reviewed.

        ג'וי פלד (אולספנגר), גיל זלצמן, אלן אפטר
        עמ'

        ג'וי פלד (אולספנגר), גיל זלצמן, אלן אפטר

         

        המרכז לבריאות הנפש "גהה", מרכז רפואי רבין, קמפוס ביילינסון פ"ת, הפקולטה לרפואה סאקלר, אוניברסיטת ת"א

         

        שיעור האלימות בחברה המערבית בכלל ובישראל בפרט נמצא בעלייה מתמדת, והפך להיות גורם משמעותי לתחלואה ותמותה. האלימות מהווה בעיה חברתית, חוקית וסוגיה בבריאות הציבור. בחודשים האחרונים, מדווח בעיתונות הכתובה והאלקטרונית על מעשי אלימות ורצח של חולי נפש. בחלקם היו החולים בקשר כלשהו עם שירותי בריאות הנפש בעברם. בנוסף, בחלק מהמצבים בהם ננקט פשע אלים, טוען הנאשם לאי-שפיות כהגנה משפטית. בסקירה זו, נדון בשאלה האם חולי נפש בכלל וחולי סכיזופרניה בפרט אלימים יותר משאר האוכלוסייה, והאם הפשע שמבצע חולה הנפש שונה באיפיוניו מפשעים המבוצעים על ידי עבריינים שאינם חולים.

        פברואר 2001

        מוניק פרץ נחום, הדסה גולדברג, אברהם קוטן, יצחק מלר, אלנה קריבוי, אברהם לורבר, לאה בנטור, אברהם ליטמן, ויויאן גורנברג, מרים וייל בן-הרוש
        עמ'

        Long-Term Sequelae of Malignant Tumors in Childhood

         

        N. M. Peretz, H. Goldberg, A. Kuten, I. Meller, E. Krivoi, A. Lorber, L. Bentur, A. Lightman, V. Gorenberg, M. Ben Arush-Weyl

         

        Pediatric Hematology-Oncology Dept., Oncology Center, Pediatric Cardiology Unit, Pulmonology and Gynecology Depts., and Pediatric Endocrinology Unit; Rambam Medical Center and Technion-Israel Institute of Technology, Haifa; and Orthopedic-Oncology Unit, Tel Aviv-Sourasky Medical Center and Tel Aviv University

         

        110 children with malignant diseases (leukemia excepted) who survived 5-20 years (median 9) post-therapy were followed (1996-1998). Median age during follow-up was 15 years (range 5-23). The most common malignancies were brain tumors, lymphoma, retinoblastoma and Wilm's tumor.

        The 174 late side-effects included endocrine disorders (19%), cognitive impairment (14%), orthopedic dysfunction (12%), alopecia (12%), dental damage (11%), psychological (8%) and neurological (8%) disturbances, and azoospermia or amenorrhea (5%). There was no cardiac or renal damage and no second malignancy.

        29% of side-effects were severe. There was significant reduction in quality of life in 54 (49%), in 27 of whom it was severe enough to require psychological intervention. Treatment of brain tumor caused 98 late side-effects in 28 patients (sequelae-to-patient ratio [SPR] 3.3). Most cognitive, endocrine and neurological disorders, and most cases of alopecia, dental and psychological difficulties were in these patients. There were frequent late complications in those treated for retinoblastoma (SPR 1.8), and bone or soft tissue sarcomas (SPR 0.8). Those treated for Wilm's tumor had few side-effects (SPR 0.4).

        Late side effects were most frequent after radiation, reaching as high as SPR 2.4. It averaged only 0.5 in those treated with chemotherapy alone or in combination with surgery.

        Reduction of late side-effects in these patients requires using less toxic modalities, as long as cure rate is not compromised. When considering secondary strategies, screening for early detection of late complications would enable immediate solutions, such as hormonal replacement or providing compensating skills for post-treatment disability.
         

        יצחק בליקשטיין
        עמ'

        התפיסה המקובלת היא, כי חיתוך דופן אלקטיבי אשר נעשה ללא הוריה רפואית הוא פעולה פסולה. בעשור האחרון למאה ה-20, הובעו דעות שחלקו על תפיסה זו והתעורר ויכוח לגבי מקומה של הלידה הלדנית במאה ה- 21. הוויכוח אשר זכה לתהודה תקשורתית רבה החל בבריטניה והתעורר אף בישראל, בה שיעור חיתוכי הדופן עולה בהתמדה. עפ"י הנתונים שנאספו ע"י יו"ר החוג לרפואה סב-לידתית והוצגו בכינוס השנתי האחרון (7 ביולי 2000), היה השיעור הממוצע של חיתוכי הדופן בשנת 1999 כדי 14.6% מכלל הלידות בישראל, פי שלושה מהשיעור בשנת 1977 (5.5%) ובשליש יותר לעומת השיעור חמש שנים קודם לכן (11.3%). בסקירה של בן-הרוש וחב' (בגיליון זה), נדונה השאלה של ניהול לידה פעיל בתקופתנו. לאור הוויכוח לגבי חיתוך-דופן עפ"י בקשת היולדת (cesarean section upon maternal request) נראית שאלה זו לכאורה ארכאית. לפיכך, בצד ניהול לידה פעיל, יש להכיר את הוויכוח לגבי אופייה של הלידה הלדנית במאה ה- 21.

        נובמבר 2000

        יצחק רוזן, יאיר לוי ויהודה שינפלד
        עמ'

        Pulmonary Adenocarcinoma in Myasthenia Gravis - Auto-Immunity and Late Development of Malignancy

         

        Yitzhak Rosen, Yair Levy, Yehuda Shoenfeld

         

        Dept. of Internal Medicine B, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University

         

        We report a 75-year-old man with myasthenia gravis for many years, who was hospitalized because of cough, fever, and dyspnea. Chest x-ray revealed a bilateral pleural effusion. Adenocarcinomatous cells were found in the pleural fluid. Computerized tomography of the chest showed widespread pulmonary dissemination of the tumor.

        The relationship between myasthenia gravis, an autoimmune disease involving the motor end-plate, and malignancy (thymoma) has been widely recognized. Current literature documents few reports of lung malignancies with concurrent development of myasthenia gravis. A tentative explanation, based on current research, is provided for the possible role of myasthenia gravis and the late development of lung cancer. Moreover, a model for the autoimmune phenomenon and the development of late malignancies will be provided with explicit explanations. It is important to search for occult, developing malignancies in newly diagnosed autoimmune diseases.

        אוקטובר 2000

        גל גולדשטיין, עופר שפילברג, פיה רענני, אנג'לה שטרית ויצחק בן בסט
        עמ'

        Acute Lymphoblastic Leukemia in Adults Treated with German Multicenter Study Group Protocols

         

        G. Goldstein, O. Shpilberg, P. Raanani, A. Chetrit, I. Ben-Bassat

         

        Institutes of Hematology and of Clinical Epidemiology, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University

         

        Acute lymphoblastic leukemia (ALL) is a malignant disease whose incidence is relatively low among adults, unlike in children. Adults with ALL have a lower rate of long-term disease-free survival. During the last 20 years, a German multicenter group has shown that their protocol have achieved good results in adult ALL.

        We reviewed the medical records of 35 ALL patients, aged 19-63 years, whome we treated with these protocol (1988-1997). The remission rate was 94%. At a median follow-up of 46 months the 2-year overall survival was 54% and the disease-free survival was 94%. Although 2 patients died of bone marrow transplant complications, no death was directly associated with drug toxicity. The main grade 3 or 4 side effects (WHO classification) were neutropenia (91%), thrombocytopenia (71%) and anemia (71%).

        With there protocols we achieved high overall and disease-free survival rates, especially in comparison with other reports. Despite the high rate of severe treatment toxicity, there were no fatalities directly related to treatment. These results emphasize the need to concentrate treatment of adult ALL patients in large medical centers with expertise in the use of the complicated treatment protocols required.

        ספטמבר 2000

        אברהם אביגדור, יזהר הרדן, עופר שפילברג, פיה רענני, איתמר גרוטו ויצחק בן-בסט
        עמ'

        High-Dose Chemotherapy and Autologous Stem Cell Trans-Plantation for Refractory and Relapsing Hodgkin's Disease

         

        A. Avigdor, I. Hardan, O. Shpilberg, P. Raanani, I. Grotto, I. Ben-Bassat

         

        Hematology Institute and Hemato-oncology Unit, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University

         

        High dose chemotherapy and autologous stem cell transplantation are widely used in relapsed and primary refractory Hodgkin's disease. We transplanted 42 patients with Hodgkin's disease between 1990-1998. Median follow-up was 31 months (range 1-102). 29 (69%) were transplanted after relapse and 13 (31%) were refractory to first line therapy. Median age at transplantation was 29 years (range 19-58) and 23 (55%) were males.

        All were treated with the BEAM protocol (carmustine, etoposide, cytarabine and melphelan). 18 who were in remission received radiotherapy following transplantation. The source of the stem cells was bone marrow in 17% and peripheral blood in 83%. At initial diagnosis: 57% had stage III-IV disease and B symptoms were present in 52%. 75% were treated with MOPP, ABVD or with related versions. Radiotherapy followed in 52%. Prior to transplantation, 45% of the relapsed group were in the advanced stage. 33% and 12% of all patients had lung and bone involvement, respectively.

        The complete remission rate was 86% for the 2 groups. 2 (5%) died from transplant-related complications and MDS/AML developed in 2 (5%) after transplantation. The 3-year overall survival (OS) and disease-free survival (DFS) were 68% and 60%, respectively. The 3-year OS for the relapsed group was 64% compared with 76% for the refractory group, and the 3-year DFS for the relapsed group was 60% vs. 42% for the refractory group (neither difference significant). Radiotherapy following transplantation did not have a beneficial effect on DFS. No prognostic factors for outcome of transplantation were found, most probably due to the limited number of patients and the high variability of disease characteristics.

        We conclude that high dose chemotherapy and autologous stem cell transplantation are effective and relatively safe for relapsed or primary refractory Hodgkin's disease. The DFS at 3 years was longer for those transplanted after relapse than those with primary refractory disease, but not significantly. Patients with primary refractory disease can be salvaged with high dose chemotherapy.

        יוני 2000

        יצחק פפו, תפחה הורן, הרברט מרדד וראובן אורדע
        עמ'

        Breast Tumors Demonstrated by Tc-99m Sestamibi Scintimammography 


        Itzhak Pappo, Tifha Horne, Herbert Merdad, Ruben Orda

         

        Dept. of Surgery A, Institute of Nuclear Medicine and Dept. of Pathology, Assaf Harofeh Medical Center, Zrifin; and Sackler Faculty of Medicine, Tel Aviv University

         

        Breast cancer can be detected by scintimammography using Tc-99m sestamibi (MIBI). The method is highly accurate, sensitive and specific. Histologically, most of the tumors have been adenocarcinomas.

        We present 2 women with rare breast tumors, primary squamous cell carcinoma and malignant phyllodes tumor. In both, mammography and cytological biopsy were not diagnostic, but MIBI scintimammography demonstrated focal uptake in the diseased breast.

        יצחק וינוגרד, ברוך קלין, א' זילביגר וגדעון אשל
        עמ'

        Aortopexy for Tracheomalacia in Infants and Children

         

        I. Vinograd, B. Klin, A. Silbiger, G. Eshel

         

        Depts. of Pediatric Surgery, and Anesthesia, Dana Children's Hospital, Sourasky-Tel Aviv Medical Center;  Dept. of Pediatric Surgery and Intensive Care Unit, Assaf Harofeh Medical Center, and Sackler Faculty of Medicine, Tel Aviv University

         

        During the past 12 years (1985-1998), 28 infants and children were operated on here for tracheomalacia. The diagnosis was made in all using rigid bronchoscopy. During the examination the infants breathed spontaneously, but the trachea collapsed on forced expiration.

        Indications for surgery were repeated cyanotic spells ("dying spells") in 22, recurrent pneumonia, and inability to extubate (in 8). In 11 there were more than 1 indications. Age at surgery was from 7 days to 3 years (average 11.7 months).

        All 28 children underwent bronchoscopy and guided aortopexy via a left-third intercostal approach. The ascending aorta and aortic arch (and in 6 the proximal innominate artery as well) were lifted anteriorly, using 3-5 non-absorbable sutures (5.0). The sutures were placed through the adventitia of the great vessels and then passed through the sternum.

        Respiratory distress was significantly improved in 21. Another 2 required external tracheal stenting with autologous rib grafts, and in 1 other an internal Palmaz stent was introduced for tracheal stability. In 4 aortopexy failed, 1 of whom had tracheobronchomalacia throughout, and another 3 had laryngomalacia which required tracheostomy to relieve the respiratory symptoms.

        Postoperative complications were minor: pericardial effusion in 1 and relaxation of the left diaphragm in another. 1 infant subsequently died, of unknown cause 10 days after operation, after having been extubated on the 1st postoperative day. On long-term follow-up (6 months to 12 years) 25 were found free of residual respiratory symptoms and 3 remained with a tracheostomy.

        Thus, infants and children with severe tracheomalacia associated with severe respiratory symptoms, can be relieved by bronchoscopic guided suspension of the aortic arch to the sternum.

        מאי 2000

        אלון הריס, חנא ג' גרזוזי, מירה הריס יצחק, ניר שהם ודניאל ר' הולנד.
        עמ'

        Color Doppler Imaging of Central Retinal Artery in Retinopathy of Prematurity

         

        Alon Harris, Hanna J. Garzozi, Mira Harris-Izhak, Nir Shoham, Daniel R. Holland

         

        Depts. of Ophthalmology, Indiana University School of Medicine, Indianapolis and of HaEmek Medical Center, Afula; and Eye Health Northwest, Portland, Oregon

         

        Color Doppler imaging (CDI) is a noninvasive technique, combining 2-dimensional brightness-modulated (B-mode) ultrasound evaluation of eye and orbital structures, with simultaneous color-coded Doppler imaging of orbital blood flow. It has been used to characterize various ophthalmic disorders in adults. Currently there is no data describing orbital blood flow parameters in either normal children or in those with ophthalmic disease, such as the retinopathy of prematurity (ROP).

        We evaluated blood flow in the central retinal artery of preterm infants undergoing examination for ROP. We also investigated whether useful readings could be obtained on a consistent basis, and the reproducibility of differences in central retinal artery blood flow between subjects with and without ROP (including the influence of "plus" disease).


        We obtained hemodynamic readings in 43 of 46 eyes of preterm infants. 13 eyes had no signs of ROP; 18 had ROP (at least stage 1) without "plus" disease, and 12 had ROP with "plus" disease. There were no statistically significant differences in systolic blood flow velocity within the 3 groups. However the average velocity was slower in the "plus" disease group, correlating with the clinical finding of dilated and tortuous blood vessels which characterize the posterior retina of ROP eyes with "plus" disease.

        אפריל 2000

        בן-ציון סילברסטון, יצחק אייזנמן, כרמית לנדוי ועקב רוזנמן
        עמ'

        Non-Penetrating Deep Sclerectomy without Collagen Implantfor Glaucoma

         

        Ben Zion Silverstone, Isaac Aizenman, Carmit Landau, Yaacov Rozenman

         

        Ophthalmology Dept., Shaare Zedek Medical Center, Jerusalem

         

        Deep sclerectomy (DS) can be used in glaucoma with increased intraocular pressure when medical treatment fails. It involves removing part of the ocular drainage apparatus. Resistance to intraocular fluid drainage is decreased, improving drainage and decreasing intraocular pressure. By avoiding anterior chamber penetration, DS diminishes frequency of the complications of filtering surgery.

        24 eyes of 23 patients underwent DS for primary or secondary open angle glaucoma with elevated intraocular pressure not controlled medically. It included preparation of a 4.0 x 4.0 mm limbal-based external scleral flap, dissecting and removing most of an internal scleral flap (leaving it 1 mm smaller than the external flap), unroofing Schlemm's canal and removing fine endothelial tissue lining its inner walls. The external scleral flap was then repositioned and sutured. Collagen implants were not used. In some cases DS was combined with extracapsular cataract extraction and intra-ocular lens implantation.

        Mean intraocular pressure decreased from 24.8‏3.9 mmHg initially to 12.8‏4.4 mmHg 6 months after operation (p<0.0001). There was no difference in postoperative intra-ocular pressure between DS as a single procedure or as part of a combined operation. Comations were mild and of short duration.

        If long-term follow-up shows that lowered intraocular pressures are maintained, DS should be a surgical option in earlier stages of glaucoma.

        דוד צייגר, אריה אריש, גד שקד, נטע שיאון-ורדי ויצחק לוי
        עמ'

        Acute Ischemia of the Lesser Gastric Curvature 


        D. Czeiger, A. Ariche, G. Shaked, N. Sion-Vardi, I. Levi

         

        Trauma Service, Dept. of Surgery, and Pathology Institute, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheba

         

        The rich blood supply of the stomach protects it from ischemia and necrosis. Acute gastric ischemia, an emergency with high mortality, is rare. Atherosclerosis is the leading cause of acute ischemia, and the lesser curvature of the stomach is more vulnerable due to its relatively lesser blood supply. Reduction in gastric blood supply usually presents as chronic disease characterized by gastritis, gastric ulcer, or gastroparesis.

        Gastroscopy can identify lesions of the gastric mucosa, and angiography demonstrates occluded vessels. Treatment of acute gastric ischemia is surgical, with total gastrectomy preferred over partial resection.

        יוסף לבצלטר, גרשון פינק, אליעזר קליינמן, יצחק רוזנברג ומרדכי ר' קרמר
        עמ'

        Preflight Assessment by Hypoxic Inhalation Test in Cardio-Pulmonary Patients 


        J. Lebzelter, G. Fink, E. Kleinman, I. Rosenberg, M.R. Kramer

         

        Pulmonology Institute, Rabin Medical Center, Beilinson Campus, Petah Tikva

         

        Flying may expose passengers to hypoxic conditions, which may induce hypoxemia, particularly in those with chronic heart and/or lung disease. Onset of dyspnea, wheezing, chest pain, cyanosis and right heart failure can lead to urgent need for oxygen during flight. The hypoxia inhalation test (HIT) provides a safe and simple means of identifying those who may develop hypoxemia during flight.

        We report our experience with 48 self-reporting patients who underwent HIT prior to pre-planned air travel. They inhaled for 15-minute periods a reduced oxygen concentration (F1O2 15%) under normobaric conditions, during which O2 saturation was monitored by pulse oximeter; electrocardiogram, blood pressure and symptoms were also monitored. O2 saturation of 85% (PaO2 50 mm Hg) was considered a positive test. In the 8 cases (17%) with a positive test, 5 had chronic obstructive pulmonary disease and 3 had cardiovascular and/or combined heart-lung disease.

        We calculated predicted O2 partial pressure in altitude (PaO2 ALT) and compared it to actual results in the 8 patients with a positive HIT. In 5, use of the predicted formula would have under-diagnosed the hypoxemia that developed during the HIT. Thus, the results of the HIT changed treatment strategy in these patients. We recommend that patients with positive tests use O2 (2LPM or 4LPM) during flight.

        HIT is practical and of potential benefit in the objective assessment of patients with various degrees of heart, lung or combined heart-lung disease. Clinicians should be aware of the relative risk of hypoxia during flight in such patients, and of the value of HIT in identifying them, leading to increase in its use.

        מרץ 2000

        מיכאל מיכיילביץ, אהוד לבל ומנחם יצחקי
        עמ'

        SYME Amputation for Foot Infections in Diabetics 


        Michael Michailevich, Ehud Lebel, Menachem Itzchaki

         

        Dept. of Orthopedics, Shaare Zedek Medical Center, Jerusalem

         

        Syme ankle disarticulation for foot infections in diabetics with concomitant peripheral vascular disease is often unsuccessful. The need for re-amputation usually results from recurrent infection or ischemia of the posterior heel flap. We present 5 such cases of deep foot infections in diabetics who underwent Syme amputation after failure of local debridement. All patients needed reamputation in 4-18 days for ischemia of the flap.

        הבהרה משפטית: כל נושא המופיע באתר זה נועד להשכלה בלבד ואין לראות בו ייעוץ רפואי או משפטי. אין הר"י אחראית לתוכן המתפרסם באתר זה ולכל נזק שעלול להיגרם. כל הזכויות על המידע באתר שייכות להסתדרות הרפואית בישראל. מדיניות פרטיות
        כתובתנו: ז'בוטינסקי 35 רמת גן, בניין התאומים 2 קומות 10-11, ת.ד. 3566, מיקוד 5213604. טלפון: 03-6100444, פקס: 03-5753303